4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv.
-
4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv.
structure -
-
CAS No:
61230-25-9
-
Formula:
C40H60BO14.Na
-
Chemical Name:
4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv.
-
Synonyms:
Borate(1-),[(1R,2R,5S,6R,8S,9E,12R,14S,17R,18R,19R,22S,23R,25S,26E,29R,31S,34R)-1,2,18,19-tetra(hydroxy-κO)-12,29-dihydroxy-6,13,13,17,23,30,30,34-octamethyl-4,7,21,24,35,37-hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriaconta-9,26-diene-3,20-dionato(4-)]-,sodium (1:1),(T-4)-;Aplasmomycin;Borate(1-),[(1R,2R,5S,6R,8S,9E,12R,14S,17R,18R,19R,22S,23R,25S,26E,29R,31S,34R)-1,2,18,19-tetra(hydroxy-κO)-12,29-dihydroxy-6,13,13,17,23,30,30,34-octamethyl-4,7,21,24,35,37-hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriaconta-9,26-diene-3,20-dionato(4-)]-,sodium,(T-4)-;4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv.;ICI 122378;Sodium [T-4-(1R,2R,5S,6R,8S,9E,12R,14S,17R,18R,19R,22S,23R,25S,26E,29R,31S,34R)]-[1,2,12,18,19,29-hexahydroxy-6,13,13,17,23,30,30,34-octamethyl-4,7,21,24,35,37-hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriaconta-9,26-diene-3,20-dionato(4-)-O1,O2,O18,O19]borate(1-);(+)-Aplasmomycin
-
CAS No:
4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv. Basic Attributes
798.701
798.397381 g/mol
188EIU3O75
Characteristics
167 Ų
283-285° (dec)
LD50 i.p. in mice: 125 mg/kg (Okami)
D22 +225° (c = 1.24 in chloroform)
Computed Properties
Molecular Weight:798.7
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:15
Exact Mass:798.3973810
Monoisotopic Mass:798.3973810
Topological Polar Surface Area:167
Heavy Atom Count:56
Complexity:1450
Defined Atom Stereocenter Count:16
Defined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Benzene, 1,1′-methylenebis-, dibromomethyl deriv.
99688-47-8
-
15H-Pyrrolo(2,1-f)(1,15,4,7,10,20)dioxatetraazacyclotricosine, cyclic peptide deriv.
77327-04-9
-
Phosphonic acid, P,P′-[[[2-[[2-[(phosphonomethyl)amino]ethyl]amino]ethyl]imino]bis(methylene)]bis-, N-(phosphonomethyl) deriv.
68785-01-3
-
Benzene, 1,1′-oxybis-, monochloro bis(2-methylpropyl) deriv. Formula
70624-14-5
-
2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[4-(6-methyl-2-benzothiazolyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methylphenyl)azo]-, monosulfo deriv. Formula
69013-32-7
-
Tetradecanamide, N-(2-aminoethyl)-, N-(2-aminoethyl) deriv. Formula
73791-58-9
-
Erythromycin, o-sulfobenzoyl deriv. Structure
6293-80-7
-
8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine,gadolinium deriv. Structure
156436-89-4
-
What is 1H-Indene, 2,3-dihydro-1,1,3-trimethyl-3-phenyl-, octabromo deriv.
155613-93-7
-
What is Benzene, 1,1′-(1-methyl-1,3-propanediyl)bis-, didehydro deriv.
54140-12-4
4,7,21,24,35,37-Hexaoxapentacyclo[29.3.1.15,8.114,18.122,25]octatriacontane,aplasmomycin deriv.
SDSRequest for Quotation